- Home
- WMK vs IMVT Comparison
WMK vs IMVT Comparison
Compare WMK & IMVT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- WMK
- IMVT
- Stock Information
- Founded
- WMK 1912
- IMVT N/A
- Country
- WMK United States
- IMVT United States
- Employees
- WMK N/A
- IMVT N/A
- Industry
- WMK Food Chains
- IMVT Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- WMK Consumer Staples
- IMVT Health Care
- Exchange
- WMK Nasdaq
- IMVT Nasdaq
- Market Cap
- WMK 2.1B
- IMVT 2.5B
- IPO Year
- WMK N/A
- IMVT N/A
- Fundamental
- Price
- WMK $75.78
- IMVT $14.85
- Analyst Decision
- WMK
- IMVT Buy
- Analyst Count
- WMK 0
- IMVT 10
- Target Price
- WMK N/A
- IMVT $40.14
- AVG Volume (30 Days)
- WMK 163.7K
- IMVT 1.2M
- Earning Date
- WMK 05-07-2025
- IMVT 05-29-2025
- Dividend Yield
- WMK 1.79%
- IMVT N/A
- EPS Growth
- WMK 6.00
- IMVT N/A
- EPS
- WMK 3.99
- IMVT N/A
- Revenue
- WMK $4,810,301,000.00
- IMVT N/A
- Revenue This Year
- WMK N/A
- IMVT $108.88
- Revenue Next Year
- WMK N/A
- IMVT N/A
- P/E Ratio
- WMK $19.01
- IMVT N/A
- Revenue Growth
- WMK 1.23
- IMVT N/A
- 52 Week Low
- WMK $60.93
- IMVT $12.72
- 52 Week High
- WMK $90.23
- IMVT $34.47
- Technical
- Relative Strength Index (RSI)
- WMK 42.87
- IMVT 50.48
- Support Level
- WMK $75.32
- IMVT $13.79
- Resistance Level
- WMK $78.99
- IMVT $15.22
- Average True Range (ATR)
- WMK 2.28
- IMVT 0.69
- MACD
- WMK -0.09
- IMVT 0.13
- Stochastic Oscillator
- WMK 33.44
- IMVT 78.24
About WMK Weis Markets Inc.
Weis Markets Inc is a U.S.-based company that is principally engaged in retailing food products in Pennsylvania and surrounding states. The company's products mainly belong to the following categories: center-store goods, fresh goods, pharmacy services, fuel, and others. The center-store goods include groceries, dairy products, frozen foods, alcoholic beverages, and general merchandise items. The fresh goods include meats, seafood, floral, prepared foods, and bakery products. The center-store goods and fresh goods jointly account for the majority of the company's total revenue.
About IMVT Immunovant Inc.
Immunovant Inc is a clinical-stage biopharmaceutical company. It is focused on enabling normal lives for patients with autoimmune diseases. The company's product includes batoclimab and IMVT-1402 targets the neonatal Fc receptor (FcRn).